{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:27:37Z","timestamp":1790796457282,"version":"4.1.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,3,20]],"date-time":"2017-03-20T00:00:00Z","timestamp":1489968000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cerebellum"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s12311-017-0851-z","type":"journal-article","created":{"date-parts":[[2017,3,20]],"date-time":"2017-03-20T04:16:48Z","timestamp":1489983408000},"page":"868-871","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Low-Titre GAD Antibody-Associated Late-Onset Cerebellar Ataxia with a Significant Clinical Response to Intravenous Immunoglobulin Treatment"],"prefix":"10.1007","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7401-2053","authenticated-orcid":false,"given":"Timotej","family":"Petrijan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marija","family":"Menih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,20]]},"reference":[{"issue":"11","key":"851_CR1","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/ncpneuro0319","volume":"2","author":"BL Fogel","year":"2006","unstructured":"Fogel BL, Perlman S. An approach to the patient with late-onset cerebellar ataxia. Nat Clin Pract Neurol. 2006;2(11):629\u201335.","journal-title":"Nat Clin Pract Neurol"},{"key":"851_CR2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40673-015-0034-y","volume":"2","author":"H Mitoma","year":"2015","unstructured":"Mitoma H, Hadjivassiliou M, Honnorat J. Guidelines for treatment of immune-mediated cerebellar ataxias. Cerebellum & Ataxias. 2015;2:14.","journal-title":"Cerebellum & Ataxias"},{"key":"851_CR3","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/mds.22129","volume":"23","author":"M Hadjivassiliou","year":"2008","unstructured":"Hadjivassiliou M, Boscolo S, Tongiorgi E, Grunewald RA, Sharrack B, Sanders DS, et al. Cerebellar ataxia as a possible organ specific autoimmune disease. Movement Disord. 2008;23:1270\u2013377.","journal-title":"Movement Disord"},{"key":"851_CR4","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s12311-015-0664-x","volume":"15","author":"H Mitoma","year":"2016","unstructured":"Mitoma H, Adhikari K, Aeschlimann D, Chattopadhyay P, Hadjivassiliou M, Hampe CS, et al. Consensus paper: neuroimmune mechanisms of cerebellar ataxias. Cerebellum. 2016;15:213\u201332.","journal-title":"Cerebellum"},{"key":"851_CR5","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1093\/brain\/awn183","volume":"131","author":"A Saiz","year":"2008","unstructured":"Saiz A, Blanco Y, Sabater L, Gonz\u00e1lez F, Bataller L, Casamitjana R, et al. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain. 2008;131:2553\u201363.","journal-title":"Brain"},{"key":"851_CR6","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00415-009-5431-9","volume":"257","author":"F Graus","year":"2010","unstructured":"Graus F, Saiz A, Dalmau J. Antibodies and neuronal autoimmune disorders of the CNS. J Neurol. 2010;257:509\u201317.","journal-title":"J Neurol"},{"key":"851_CR7","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1001\/jamaneurol.2014.1011","volume":"71","author":"H Ari\u00f1o","year":"2014","unstructured":"Ari\u00f1o H, Gresa Arribas N, Blanco Y, Mart\u00ednez Hern\u00e1ndez E, Sabater L, Petit Pedrol M, et al. Cerebellar ataxia and glutamic acid decarboxylase antibodies: immunologic profile and long-term effect of immunotherapy. JAMA Neurol. 2014;71:1009\u201316.","journal-title":"JAMA Neurol"},{"key":"851_CR8","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s12311-012-0411-5","volume":"12","author":"K Nanri","year":"2013","unstructured":"Nanri K, Niwa H, Mitoma H, Takei A, Ikeda J, Harada T, et al. Low-titer anti-GAD-antibody-positive cerebellar ataxia. Cerebellum. 2013;12:171\u20135.","journal-title":"Cerebellum."},{"key":"851_CR9","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1001\/archneur.58.2.225","volume":"58","author":"J Honnorat","year":"2001","unstructured":"Honnorat J, Saiz A, Giometto B, Vincent A, Brieva L, Andres C, et al. Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients. Arch Neurol. 2001;58:225\u201330.","journal-title":"Arch Neurol"},{"key":"851_CR10","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/cei.12185","volume":"175","author":"F Leypoldt","year":"2014","unstructured":"Leypoldt F, Wandinger KP. Paraneoplastic neurological syndromes. Clin Exp Immunol. 2014;175:336\u201348.","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"851_CR11","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s12311-013-0534-3","volume":"13","author":"V Planche","year":"2013","unstructured":"Planche V, Marques A, Ulla M, Ruivard M, Durif F. Intravenous immunoglobulin and rituximab for cerebellar ataxia with glutamic acid decarboxylase autoantibodies. Cerebellum. 2013;13(3):318\u201322.","journal-title":"Cerebellum"},{"issue":"10","key":"851_CR12","doi-asserted-by":"crossref","first-page":"783","DOI":"10.2169\/internalmedicine.48.1802","volume":"48","author":"K Nanri","year":"2009","unstructured":"Nanri K, Okita M, Takeguchi M, Taquchi T, Ishiko T, Saito H, et al. Intravenous immunoglobulin therapy for autoantibody-positive cerebellar ataxia. Intern Med. 2009;48(10):783\u201390.","journal-title":"Intern Med"},{"key":"851_CR13","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S1474-4422(03)00534-9","volume":"10","author":"G Lauria","year":"2003","unstructured":"Lauria G, Pareyson D, Pitzolu MG, Bazzigaluppi E. Excellent response to steroid treatment in anti-GAD cerebellar ataxia. Lancet Neurol. 2003;10:634\u20135.","journal-title":"Lancet Neurol"},{"issue":"5","key":"851_CR14","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.neurol.2008.02.032","volume":"164","author":"M Bonnan","year":"2008","unstructured":"Bonnan M, Cabre P, Olindo S, Signate A, Saint-Vil M, Smadja D. Steroid treatment in four cases of anti-GAD cerebellar ataxia. Rev Neurol. 2008;164(5):427\u201333.","journal-title":"Rev Neurol"},{"issue":"4, pt 1","key":"851_CR15","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.diabet.2008.02.002","volume":"34","author":"C Bayreuther","year":"2008","unstructured":"Bayreuther C, Hieronimus S, Ferrari P, Thomas P, Lebrun C. Auto-immune cerebellar ataxia with anti-GAD antibodies accompanied by de novo late-onset type 1 diabetes mellitus. Diabetes Metab. 2008;34(4, pt 1):386\u20138.","journal-title":"Diabetes Metab"},{"issue":"2","key":"851_CR16","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1136\/jnnp.2006.089268","volume":"78","author":"S Vulliemoz","year":"2007","unstructured":"Vulliemoz S, Vanini G, Truffert A, Chizzolini C, Seeck M. Epilepsy and cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies. J Neurol Neurosurg Psychiatry. 2007;78(2):187\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"851_CR17","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1212\/WNL.52.4.857","volume":"52","author":"M Abele","year":"1999","unstructured":"Abele M, Weller M, Mescheriakov S, B\u00fcrk K, Dichgans J, Klockgether T. Cerebellar ataxia with glutamic acid decarboxylase autoantibodies. Neurology. 1999;52(4):857\u20139.","journal-title":"Neurology"},{"issue":"7","key":"851_CR18","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1212\/01.wnl.0000238389.83574.be","volume":"67","author":"NR McFarland","year":"2006","unstructured":"McFarland NR, Login IS, Vernon S, Burns TM. Improvement with corticosteroids and azathioprine in GAD65-associated cerebellar ataxia. Neurology. 2006;67(7):1308\u20139.","journal-title":"Neurology"},{"issue":"1","key":"851_CR19","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1136\/jnnp.2007.142745","volume":"80","author":"R Virgilio","year":"2009","unstructured":"Virgilio R, Corti S, Agazzi P, Santoro D, Lanfranconi S, Candelise L, et al. Effect of steroid treatment in cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies. J Neurol Neurosurg Psychiatry. 2009;80(1):95\u20136.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"851_CR20","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1590\/S0004-282X2011000700030","volume":"69","author":"JL Pedroso","year":"2011","unstructured":"Pedroso JL, Braga Neto P, Dutra LA, Barsottini OG. Cerebellar ataxia associated to anti-glutamic acid decarboxylase autoantibody (anti-GAD): partial improvement with intravenous immunoglobulin therapy. Arq Neuropsiquiatr. 2011;69(6):993.","journal-title":"Arq Neuropsiquiatr"},{"issue":"1","key":"851_CR21","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1111\/j.1468-1331.2009.02839.x","volume":"17","author":"V Nociti","year":"2010","unstructured":"Nociti V, Frisullo G, Tartaglione T, Pantanella AK, Iorio R, Tonali PA, et al. Refractory generalized seizures and cerebellar ataxia associated with anti-GAD antibodies responsive to immunosuppressive treatment. Eur J Neurol. 2010;17(1):e5.","journal-title":"Eur J Neurol"}],"container-title":["The Cerebellum"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12311-017-0851-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-017-0851-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-017-0851-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,7,5]],"date-time":"2017-07-05T06:48:49Z","timestamp":1499237329000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12311-017-0851-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,20]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["851"],"URL":"https:\/\/doi.org\/10.1007\/s12311-017-0851-z","relation":{},"ISSN":["1473-4222","1473-4230"],"issn-type":[{"value":"1473-4222","type":"print"},{"value":"1473-4230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,20]]}}}